Carnegie Investment Counsel’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Sell
5,316
-465
-8% -$141K 0.05% 234
2026
Q1
$1.24M Sell
5,781
-1,440
-20% -$322K 0.02% 300
2025
Q4
$1.24M Buy
7,221
+354
+5% +$55.1K 0.02% 303
2025
Q3
$919K Buy
6,867
+301
+5% +$31.9K 0.02% 322
2025
Q2
$639K Buy
+6,566
New +$521K 0.01% 357
2024
Q4
Sell
-2,690
Closed -$220K 475
2024
Q3
$220K Buy
2,690
+260
+11% +$22.6K 0.01% 440
2024
Q2
$259K Sell
2,430
-150
-6% -$14.4K 0.01% 420
2024
Q1
$251K Sell
2,580
-90
-3% -$7.92K 0.01% 446
2023
Q4
$209K Buy
+2,670
New +$182K 0.01% 466
2022
Q2
Sell
-3,990
Closed -$215K 494
2022
Q1
$215K Buy
3,990
+750
+23% +$43.7K 0.01% 460
2021
Q4
$233K Buy
+3,240
New +$203K 0.01% 463

Other funds holding LRCX

Carnegie Investment Counsel's LRCX Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Lam Research (LRCX) stake by 8% in Q2 2026, selling an estimated $141K and leaving 5,316 shares worth $2.3M. The position accounts for 0.05% of the portfolio, ranked #234.

Carnegie Investment Counsel first reported a position in LRCX in Q4 2021 and has held it in 11 quarters since. 1,951 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Carnegie Investment Counsel held 5,316 shares of Lam Research worth $2.3M as of Q2 2026.
  • Carnegie Investment Counsel sold 465 Lam Research shares in Q2 2026, an estimated $141K.
  • Lam Research made up 0.05% of Carnegie Investment Counsel's portfolio in Q2 2026, its #234 holding.
  • Carnegie Investment Counsel first reported a position in Lam Research in Q4 2021 and has held it in 11 quarters since.
  • 1,951 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.